This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
The treatment for Beta-Thalassemia is expected to cost $2.2 million and will be available in the United States this year.
A cutting-edge cure or CRISPR catastrophe? That’s the question facing regulators.
A new kind of GMO is going by different names, and largely escaping regulation as it enters grocery stores.
